Overview Of The Main Bacterial Infections In Humans
DOI:
https://doi.org/10.12775/QS.2024.23.54786Keywords
Pathogenic bacteria, Bacterial infections, Carrier, Antibiotherapy, Prevention of infectionAbstract
Bacterial infections are one of the main challenges of modern medicine, affecting millions of people every year. The ubiquitous microorganisms, such as bacteria, cause many various diseases that can be asymptomatic or mild as well as life-threatening. The purpose of the research is to gain insight into contemporary knowledge about pathogenic bacteria causing the most common diseases in human beings: Gram-Positive Cocci, including S. aureus, S. epidermidis, S. pyogenes, S. agalactiae, E. faecalis, S. pneumoniae, Gram-Negative Cocci, such as N. gonorrhoeae, N. meningitidis, Gram-Negative Bacilli (Enterobacteriaceae), like E. coli, Salmonella, Shigella, K. pneumoniae as well as bacteria of the genus Clostridioides, Pseudomonas, Acinetobacter i Mycobacteria.
Information searches were carried out in online databases, scientific, and educational editions, including PubMed, Elsevier, Research Gate, Web of Science, Springer.
Bacterial infections are still a huge concern in the modern world. It is necessary not only to constantly update knowledge but also to carry out researces to improve the effectiveness of treatment and prevention against these pathogens.
References
Tong SYC, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603-661. doi:10.1128/CMR.00134-14
Virella G, Mikrobiologia i choroby zakaźne, Paweł S Berezowicz (tłum.), Piotr Bogumił Heczko (red.), Wrocław: Urban & Partner, 2000, s. 181, ISBN 83-85842-59-4, OCLC 749874380.
Dzierżanowska D. Antybiotykoterapia praktyczna. ISBN 978-83-7522-013-1. Wydanie VI. 2024.
Pawlak M, Żmuda-Trzebiatowski P, Streptococcus pyogenes – zakażenie, objawy, leczenie, powikłania, medonet.pl, 2019.
Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae). Microbiol Spectr. 2019;7(2). doi:10.1128/microbiolspec.GPP3-0007-2018
Van Tyne D, Martin MJ, Gilmore MS. Structure, function, and biology of the Enterococcus faecalis cytolysin. Toxins (Basel). 2013;5(5):895-911. doi:10.3390/toxins5050895
Suaya JA, Fletcher MA, Georgalis L, et al. Identification of Streptococcus pneumoniae in hospital-acquired pneumonia in adults. J Hosp Infect. 2021;108:146-157. doi:10.1016/j.jhin.2020.09.036
Hill SA, Masters TL, Wachter J. Gonorrhea - an evolving disease of the new millennium. Microb Cell. 2016 Sep;3(9):371-389. doi:10.15698/mic2016.09.524
Berger RE, Alexander ER, Harnisch JP, et al. Etiology, manifestations and therapy of acute epididymitis: prospective study of 50 cases. J Urol. 1979;121(6):750-754. doi:10.1016/s0022-5347(17)56978-5
Lian WQ, Luo F, Song XL, Lu YJ, Zhao SC. Gonorrhea and prostate cancer incidence: an updated meta-analysis of 21 epidemiologic studies. Med Sci Monit. 2015;21:1902-1910. doi:10.12659/MSM.893579
Hitchcock PJ, Robinson Jr EN, McGee ZA, Koomey JM. "Neisseriae: Gonococcus and Meningococcus". In Schaechter M, Medoff G, Eisenstein BI (eds.). Mechanisms of Microbial Disease (2nd ed.). 1993; Baltimore: Williams & Wilkins. p. 231. ISBN 9780683076066.
Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(12):853-861. doi:10.1016/S1473-3099(10)70251-6
Cianciara J, Juszczyk J. Choroby zakaźne i pasożytnicze. Lublin: CZELEJ, ISBN 978-83-60608-34-0. 2007.
Gabutti G, Stefanati A, Kuhdari P. Epidemiology of Neisseria meningitidis infections: case distribution by age and relevance of carriage. J Prev Med Hyg. 2015;56(3):E116-120.
Long SS, Prober CG, Fischer M. Principles and Practice of Pediatric Infectious Diseases. Elsevier Health Sciences, ISBN 978-0-323-46132-0. 2017.
Brigham KS, Sandora TJ. Neisseria meningitidis: epidemiology, treatment and prevention in adolescents. Curr Opin Pediatr. 2009;21(4):437-443. doi:10.1097/MOP.0b013e32832c9668
Bentley R, Meganathan R. "Biosynthesis of vitamin K (menaquinone) in bacteria". Microbiological Reviews. 1982, 46 (3): 241–80. doi:10.1128/MMBR.46.3.241-280.1982. PMC 281544. PMID 6127606
Ryan KJ, Ray CG, eds. Sherris medical microbiology: an introduction to infectious diseases (4th ed.). McGraw-Hill Professional Med/Tech. 2004, ISBN 978-0-8385-8529-0.
Bowen A. "Chapter 3: Infectious Diseases Related to Travel". The Yellow Book: Health Information for International Travel. 2016. CDC. ISBN 978-0-19-937915-6. Retrieved 22 June 2016.
"General Information Shigella – Shigellosis CDC". www.cdc.gov. 10 January 2024. Retrieved 10 January 2024. https://www.cdc.gov/shigella/about/index.html
Zaremba ML, Borowski J. Mikrobiologia lekarska. Wydawnictwo PZWL, wydanie III (dodruk). ISBN 83-200-2896-5. Strona 207, 2001.
Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539-1548. doi:10.1056/NEJMra1403772
Hensgens MPM, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother. 2012;67(3):742-748. doi:10.1093/jac/dkr508
Luciano JA, Zuckerbraun BS. "Clostridium difficile infection: prevention, treatment, and surgical management". The Surgical Clinics of North America. 2014; 94 (6): 1335–49. doi:10.1016/j.suc.2014.08.006. PMID 25440127
Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis. 1992;166(3):561-567. doi:10.1093/infdis/166.3.561
Dodin M, Katz DE. Faecal microbiota transplantation for Clostridium difficile infection, „International Journal of Clinical Practice”, 68 (3), 2014, s. 363–368, DOI: 10.1111/ijcp.12320, PMID: 24372725
Lentino JR. "Clostridial Necrotizing Enteritis". Merck M. Merck Sharp & Dohme Corp. Retrieved 2016. https://www.msdmanuals.com/professional/infectious-diseases/anaerobic-bacteria/clostridial-ne crotizin g-enteritis
"Clostridium perfringens". Center for Disease Control and Prevention. 2015-10-08. Retrieved 2016-09-27.
Todar K. "Pathogenic Clostridia, including Botulism and Tetanus". Todar's Online Textbook of Bacteriology. 2005; p. 3. Retrieved 24 June 2018.
Szczeklik A, Gajewski P. Interna Szczeklika 2017. Kraków: Wydawnictwo Medycyna Praktyczna, s. 2388–2390. ISBN 978-83-7430-517-4. 2017.
Khan AA, Zahidie A, Rabbani F, Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries – a systematic review, „BMC Public Health”, 13, 2013, s. 322, DOI: 10.1186/1471-2458-13-322, PMID: 23570611, PMCID: PMC3637612.
Felter RA, Zinns LE. Cephalic Tetanus in an Immunized Teenager: An Unusual Case Report, „Pediatric Emergency Care”, 31 (7), 2015, s. 511–513, DOI: 10.1097/PEC.0000000000000360, PMID: 25853723
"Pseudomonas aeruginosa in Healthcare Settings". Healthcare-associated Infections (HAI): Diseases and Organisms. Centers for Disease Control and Prevention. 7 May 2014.
"Pseudomonas Aeruginosa Fact Sheet" (PDF). Children's Hospital of Illinois. Archived from the original (PDF) on 2016-05-09. Retrieved 2014-11-15.
Rodríguez-Baño J et al., Acinetobacter baumannii bacteremia: clinical and prognostic features, „Enfermedades Infecciosas y Microbiología Clínica”, 21 (5), 2003, s. 242-7, DOI: 10.1016/S0213-005X(03)72930-9, PMID: 12732114
Doughari HJ, Ndakidemi PA, Human IS, Benade S. The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes Environ. 2011;26(2):101-112. doi:10.1264/jsme2.me10179
Antunes LCS, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis. 2014;71(3):292-301. doi:10.1111/2049-632X.12125
"He was dying. Antibiotics weren't working. Then doctors tried a forgotten treatment". Mother Jones. Retrieved 2018-05-17.
Diel R, Nienhaus A, Witte P, Ziegler R. Protection of healthcare workers against transmission of Mycobacterium tuberculosis in hospitals: a review of the evidence. ERJ Open Res. 2020;6(1):00317-02019. doi:10.1183/23120541.00317-2019
Taillard C, Greub G, Weber R, et al. Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey. J Clin Microbiol. 2003;41(3):1240-1244. doi:10.1128/JCM.41.3.1240-1244.2003
Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277-283.
Schmidt TM, Schaechter M. Topics in Ecological and Environmental Microbiology. Academic Press; 2011.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jakub Maciej Pieniążek, Aleksandra Padkowska, Mateusz Dobosz, Klaudia Arciszewska, Jakub Buczkowski, Małgorzata Miazga, Michał Paprocki, Anna Mataczyńska
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 86
Number of citations: 0
